BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) (Nasdaq: CYCCP) today provided an overview of recent advances in its clinical development stage programs and announced its 2008 key business objectives for these programs.
